GSK Stock Up 1.25%, GlaxoSmithKline Plans to Make 1B Doses of Coronavirus Vaccine Booster

Coinspeaker
GSK Stock Up 1.25%, GlaxoSmithKline Plans to Make 1B Doses of Coronavirus Vaccine Booster

After GlaxoSmithKline announced its plans to produce 1 billion doses of a vaccine adjuvant next year, the GSK stock price started to rise.

GSK Stock Up 1.25%, GlaxoSmithKline Plans to Make 1B Doses of Coronavirus Vaccine Booster

Coinspeaker

52 total views, 1 views today

Author: toutiao